Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Anesthesiology
|
May 29, 2012
Identification of two mutations (F758W and F758Y) in the N-methyl-D-aspartate receptor glycine-binding site that selectively prevent competitive inhibition by xenon without affecting glycine binding
Scott P Armstrong, Paul J Banks, Thomas J W McKitrick, et al.
The Journal of Antibiotics
|
January 26, 1999
Novel erythromycins from a recombinant Saccharopolyspora erythraea strain NRRL 2338 pIG1. I. Fermentation, isolation and biological activity
M S Pacey, J P Dirlam, R W Geldart, et al.
European Urology
|
September 15, 2015
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
Thomas Powles, Matthew Wheater, Omar Din, et al.
Ecology and Evolution
|
March 12, 2024
An interspecific foraging association with polar bears increases foraging opportunities for avian predators in a declining Arctic seabird colony
Andrew F Barnas, Cassandra A B Simone, Erica A Geldart, et al.
European Urology
|
December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma
Thomas Geldart, John Chester, Angela Casbard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2016
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC
Edurne Arriola, Matthew Wheater, Ian Galea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study
Peter Johnson, Ruth Challis, Ferdousi Chowdhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)
T Powles, J Brown, J Larkin, et al.
British Journal of Cancer
|
December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy
Sanjay Popat, Adam Januszewski, Mary O'Brien, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC)
R Frazer, J M McGrane, A Challapalli, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Anesthesiology
|
May 29, 2012
Identification of two mutations (F758W and F758Y) in the N-methyl-D-aspartate receptor glycine-binding site that selectively prevent competitive inhibition by xenon without affecting glycine binding
Scott P Armstrong, Paul J Banks, Thomas J W McKitrick, et al.
The Journal of Antibiotics
|
January 26, 1999
Novel erythromycins from a recombinant Saccharopolyspora erythraea strain NRRL 2338 pIG1. I. Fermentation, isolation and biological activity
M S Pacey, J P Dirlam, R W Geldart, et al.
European Urology
|
September 15, 2015
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
Thomas Powles, Matthew Wheater, Omar Din, et al.
Ecology and Evolution
|
March 12, 2024
An interspecific foraging association with polar bears increases foraging opportunities for avian predators in a declining Arctic seabird colony
Andrew F Barnas, Cassandra A B Simone, Erica A Geldart, et al.
European Urology
|
December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma
Thomas Geldart, John Chester, Angela Casbard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2016
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC
Edurne Arriola, Matthew Wheater, Ian Galea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study
Peter Johnson, Ruth Challis, Ferdousi Chowdhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)
T Powles, J Brown, J Larkin, et al.
British Journal of Cancer
|
December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy
Sanjay Popat, Adam Januszewski, Mary O'Brien, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC)
R Frazer, J M McGrane, A Challapalli, et al.
Page
of 10